PubMed Health⌕ Search

Biomedical subjects

Tim Lancaster

Publications and source records attributed to Tim Lancaster.

11 recordsLinked to original sources

Prevention of relapse after quitting smoking: a systematic review of trials.

BACKGROUND: After initially successful quit attempts, many people return to smoking within a year, reducing the public health benefits of investment in smoking cessation. We aimed to assess whether interventions designed to prevent relapse after a successful quit attempt reduce the proportion of recent quitters who return to smoking. METHODS: We searched the Cochrane Tobacco Addiction Review Group trials' register. We selected randomized or quasi-randomized controlled trials of relapse prevention interventions with a minimum follow-up of 6 months. We included people who quit on their own, underwent enforced abstinence, or were in treatment programs. We included trials comparing relapse prevention interventions with no intervention or cessation plus relapse prevention with cessation intervention alone. Two of us independently extracted data from each report, with disagreements referred to a third author. RESULTS: Forty-two studies met the inclusion criteria. The most common interventions were skills training to identify and resolve tempting situations and extended treatment contact. A few studies tested pharmacotherapy. We separately analyzed studies that randomized abstainers and those that randomized participants before their quit date. Within subgroups of trials, pooled odds ratios ranged from 0.86 to 1.30, and in most analyses, 95% confidence intervals included 1. Most studies had limited power to detect moderate differences between interventions. CONCLUSION: The evidence to date does not support the adoption of skills training or other specific interventions to help individuals who have successfully quit smoking to avoid relapse, but this is an important area for future study.

Clinical Trials as Topic↗

Nortriptyline for smoking cessation: a review.

This article reviews the efficacy of nortriptyline for smoking cessation based on a meta-analysis of the Cochrane Library. Six placebo-controlled trials have shown nortriptyline (75-100 mg) doubles quit rates (OR = 2.1). Between 4% and 12% of smokers dropped out because of adverse events, but no serious adverse events occurred. The efficacy of nortriptyline did not appear to be related to its antidepressant actions. Nortriptyline is an efficacious aid to smoking cessation with a magnitude of effect similar to that for bupropion and nicotine replacement therapies. Whether nortriptyline produces serious side effects at these doses in healthy, nondepressed smokers remains unclear because it has been tested in only 500 smokers. The finding that nortriptyline and bupropion are effective for smoking cessation but that selective serotonin-reuptake inhibitors are not suggests that dopaminergic or adrenergic, but not serotonergic, activity is important for cessation efficacy. Until further studies can verify a low incidence of significant adverse events, nortriptyline should be a second-line treatment for smoking cessation.

Antidepressive Agents, Tricyclic↗

Literature and medicine: evaluating a special study module using the nominal group technique.

OBJECTIVES: To evaluate a special study module in literature and medicine that aimed for clinical relevance. METHODS: We organised a 4-week course around themes such as empathy, death and dying, disability, madness and creativity, addiction, domestic violence, ethical dilemmas, doctor/patient communication, doctors' emotions and end of life decisions. We used a diversity of texts and genres to address these themes. We explicitly encouraged the students to engage with both content and form when studying literature. To evaluate the course we used a nominal group technique. Students identified a range of items in response to open questions about the content and methods of the course. After clarifying and reducing the items generated, they ranked them in order of importance. To investigate perceived clinical relevance, we grouped the individual items into broader themes using a previously suggested taxonomy of clinical relevance. RESULTS: The students attached the highest importance to the insights gained into patients and their experience of illness. These encompassed aspects of understanding, knowledge and empathy. They also perceived that they had improved clinically relevant skills including communication, analysis, presentation, writing and ethical reasoning. The remaining items were more broadly concerned with themes of personal growth, development and pleasure. CONCLUSIONS: There are many objectives in studying literature. We focussed on designing a special study module that explicitly emphasised clinical relevance. Our evaluation shows that students identified clinically relevant improvements in knowledge, skills and attitudes from having taken the course.

Clinical Competence↗